 Evaluation ketotifen corticosteroid-dependent idiopathic anaphylaxis possible efficacy ketotifen treatment idiopathic anaphylaxis IA open-label trial patients IA corticosteroids doses disease study patients noncorticosteroid medications eg antihistamines oral adrenergic agents regular basis treatment IA study periodic attempts corticosteroid doses reduction prednisone dose continued control disease evidence beneficial effect months administration patients probable benefits reductions alternate day prednisone dose requirement mg none mg mg mg none patient possible benefit dose reduction mg mg patients unable major decreases prednisone symptoms signs IA limitations study design efficacious treatment patients IA trials treatment IA